Clinical Trials Directory

Trials / Completed

CompletedNCT03220594

Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation

Serum Antimullerian Hormone Levels in Patients Who Underwent Hypogastric Artery Ligation

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

To observe the effects of hypogastric artery ligation on serum antimullerian hormone levels.

Detailed description

To measure and compare serum antimullerian hormone levels in patients who underwent hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy and postpartum control. The procedures performed as an emergency life saving method during delivery. The reasons for hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy were obstetric hemorrhage mainly uterine atony. The serum levels of antimullerian hormone were measured 6 months after the operations and compared with matching postpartum controls. Serum levels of FSH, LH, PRL and TSH were also measured 6 months after the operation. Further, antral follicle count measured along with the aforementioned blood tests.

Conditions

Interventions

TypeNameDescription
PROCEDUREhypogastric artery ligationhypogastric artery ligation is the ligation of the internal iliac artery to stop bleeding related to obstetrics obstetric hemorrhage Hysterectomy is the removal of the uterus if bleeding can't stop by hypogastric artery ligation

Timeline

Start date
2017-03-20
Primary completion
2017-09-20
Completion
2017-09-29
First posted
2017-07-18
Last updated
2017-10-02

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03220594. Inclusion in this directory is not an endorsement.